Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2023-06-21 Transaction in Own Shar…
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' and the subject ('Oggetto') is 'Kolinpharma, aggiornamento buy-back'. The content details the execution of a share buy-back program ('Programma di Acquisto azioni proprie') for the period June 12-16, 2023, including the number of shares purchased and the total shares held afterward. This specific activity—reporting on the company's own share transactions—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a price-sensitive communication, the core subject matter is the repurchase activity itself, making POS the most precise classification over a general Regulatory Filing (RNS) or Report Publication Announcement (RPA), as the document contains the substantive data, not just an announcement that data exists.
2023-06-21 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' (Price Sensitive Press Release) and its subject is 'Kolinpharma, aggiornamento buy-back' (Kolinpharma, buy-back update). It details the purchase of 1,000 own shares by the company during the period June 5-9, 2023, including transaction tables and the resulting total shareholding percentage. This type of announcement, detailing the execution of a share repurchase program, directly relates to changes in the company's capital structure or treasury stock transactions. The most specific category is 'Transaction in Own Shares' (POS). It is not a general Earnings Release (ER) or a comprehensive Interim Report (IR).
2023-06-17 Italian
Kolinpharma, riepilogo operazioni buy-back maggio
Transaction in Own Shares Classification · 1% confidence The document is a formal disclosure titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (Model Disclosure for Transactions in the Issuer's Securities). Section 2 details specific transactions (acquisti/vendite - purchases/sales) of the company's shares (AZIONI ORDINARIE KOLINPHARMA) conducted by an intermediary (MIT SOCIETÀ DI INTERMEDIAZIONE MOBILIARE) on behalf of the issuer, covering the period May 2023. This structure precisely matches the definition of reporting transactions in the company's own shares, which corresponds to the 'Transaction in Own Shares' category.
2023-06-09 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' (Price Sensitive Press Release) and its subject is 'Kolinpharma, aggiornamento buy-back' (Kolinpharma, buy-back update). The content details the purchase of 'azioni proprie' (own shares) during a specific period (May 29 – June 2, 2023), including the number of shares bought, the average price, and the total consideration. This activity directly relates to the company managing its own stock capital, which falls under the definition of 'Transaction in Own Shares' (POS). Although it involves capital management, the specific action described is the repurchase of shares, making POS the most precise classification over CAP (Capital/Financing Update).
2023-06-09 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" (Price Sensitive Press Release) and its subject is "Kolinpharma, aggiornamento buy-back" (Kolinpharma, buy-back update). The content details the purchase of the company's own shares during a specific period (May 22-26, 2023), including the number of shares bought, average price, and the resulting total holding of treasury shares. This activity—a company buying back its own stock—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing type code is POS.
2023-05-29 Italian
Kolinpharma,aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" (Price Sensitive Press Release) and its subject is "Kolinpharma, aggiornamento buy-back" (Kolinpharma, buy-back update). It details the purchase of 600 own shares during the period May 15-19, 2023, including the number of shares bought, weighted average price, and total consideration. This activity—a company repurchasing its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. Although it is a press release, the core content is the transaction report itself, making POS more specific than RPA or RNS.
2023-05-22 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.